Fore Kopi Indonesia Tbk. vs Ikapharmindo Putramas Tbk. — how do they compare? Fore Kopi Indonesia Tbk. trades at Rp615 (market cap 5.44T, 1.89M 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 304.92B, 13.7K 24h volume). The key difference: Fore Kopi Indonesia Tbk. is far larger — about 17.8× Ikapharmindo Putramas Tbk.'s market cap, and Fore Kopi Indonesia Tbk. is more actively traded (1.89M versus 13.7K). Which is the better fit depends on your goals.
| FORE | IKPM | |
|---|---|---|
Market Cap | 5.44T | 304.92B |
Volume | 1.89M | 13.7K |
Lot | 18.9K | 137 |
Turnover | 1.15B | 2.49M |
Average Price | 609.92 | 181.39 |
Value | 1.15B | 2.49M |
Indicative Equilibrium Price | 615 | — |
Indicative Equilibrium Volume | 1.29K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Fore Kopi Indonesia Tbk (the Company) was established in Jakarta based on Notarial Deed No. 6 dated July 3, 2018 of Jose Dima Satria, S.H., M.Kn. The Company commenced its commercial operations in August 2018. The controlling shareholder of the Company is EVLab Fore Pte. Ltd., through its ownership in Fore Holdings Pte. Ltd.
Read more on FORE →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →